Danielle Shiller
Obstetrics & Gynecology · Baltimore, MDNPI 1841212982
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $176,600 of the $221,478 with a category attached, or 79.7%. AbbVie accounts for 92.2% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2019 at $160,052 and has fallen 100.0% since, to $76 in 2025. Among obstetrics & gynecology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 437 payments — averaging $506.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$204K
- Meditrina$6K
- Duchesnay USA Incorporated$6K
- Acessa Health Inc.$3K
- Amgen$301
- Novo Nordisk$209
- plus $867 from 22 others
Across 97 payments — averaging $2596.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$153K
- Bayer$76K
- Myovant Sciences Inc.$8K
- Mitsubishi Tanabe Pharma Development America, Inc.$8K
- Ipsen Innovation$7K
What the payments were for
- Consulting fees$6,3003%
- Speaking & faculty fees$176,60080%
- Travel & lodging$32,43215%
- Food & beverage$6,0923%
- Education$550%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 315 | $204,144 |
| Meditrina | 7 | $6,341 |
| Duchesnay USA Incorporated | 13 | $6,232 |
| Acessa Health Inc. | 27 | $3,385 |
| Amgen | 18 | $301 |
| Novo Nordisk | 12 | $209 |
| Therapeuticsmd, Inc. | 7 | $108 |
| Biohaven Pharmaceuticals, Inc. | 2 | $106 |
| Amarin Pharma, Inc. | 5 | $96 |
| Merck | 6 | $96 |
| Regeneron | 1 | $76 |
| Millicent US Inc | 4 | $70 |
| Astellas Pharma US Inc | 3 | $46 |
| Eisai Inc. | 2 | $38 |
| Bayer | 2 | $29 |
| Lupin Inc. | 1 | $20 |
| GSK | 1 | $19 |
| Johnson & Johnson | 1 | $19 |
| Agile Therapeutics, Inc. | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Exeltis, USA Inc. | 1 | $16 |
| Sanofi | 1 | $15 |
| Smith+Nephew | 1 | $13 |
| Evofem Biosciences, Inc. | 1 | $13 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Avion Pharmaceuticals | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$221,478 in reported general payments places this provider in the 95th percentile of 842 obstetrics & gynecology providers in Maryland.
Other obstetrics & gynecology in Baltimore
- Karen WangBaltimore$91K
- Rebecca StoneBaltimore$88K
- Christina EnzmannBaltimore$63K
- Latasha MurphyBaltimore$41K
- Ishrat RafiBaltimore$29K
- Colleen McCormickBaltimore$29K
- Jenell ColemanBaltimore$18K
- David MatthewsBaltimore$12K
- Anne BurkeBaltimore$12K
- Michelle KushBaltimore$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.